The USPTO has officially registered the trademark "CANCERMAP" (TM86285985) for services related to providing medical information, consultancy, and advisory services. This registration, finalized on March 25, 2026, covers the use of a body map in personal medical reports to indicate pathological or laboratory disease states and diagnoses, potentially including historical data.

This registration signifies the formal granting of exclusive rights for the use of the "CANCERMAP" mark in connection with these specific medical consultancy services. While this is a trademark registration and not a regulatory rule, entities operating in the medical information and consultancy space should be aware of this registered mark to avoid potential infringement issues. No specific compliance actions are mandated by this trademark registration itself, but businesses offering similar services should ensure their branding does not conflict with this registered trademark.